000 | 01688 a2200481 4500 | ||
---|---|---|---|
005 | 20250516011521.0 | ||
264 | 0 | _c20110216 | |
008 | 201102s 0 0 eng d | ||
022 | _a1365-3024 | ||
024 | 7 |
_a10.1111/j.1365-3024.2010.01237.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDaneshvar, H | |
245 | 0 | 0 |
_aGentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis. _h[electronic resource] |
260 |
_bParasite immunology _c |
||
300 |
_a722-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnimal Structures _xparasitology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Protozoan _xblood |
650 | 0 | 4 |
_aAntiprotozoal Agents _xmetabolism |
650 | 0 | 4 |
_aDog Diseases _ximmunology |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGentamicins _xmetabolism |
650 | 0 | 4 | _aImmunity, Cellular |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 | _aInjections, Intradermal |
650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
650 | 0 | 4 |
_aInterleukin-10 _xmetabolism |
650 | 0 | 4 |
_aLeishmania infantum _xdrug effects |
650 | 0 | 4 |
_aLeishmaniasis, Visceral _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProtozoan Vaccines _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
700 | 1 | _aMolaei, M M | |
700 | 1 | _aKamiabi, H | |
700 | 1 | _aBurchmore, R | |
700 | 1 | _aHagan, P | |
700 | 1 | _aStephen Phillips, R | |
773 | 0 |
_tParasite immunology _gvol. 32 _gno. 11-12 _gp. 722-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-3024.2010.01237.x _zAvailable from publisher's website |
999 |
_c20339284 _d20339284 |